Anaveon

Developer of immunotherapies for treating cancers

placeZurich, Zurich, Switzerland calendar_todayFounded 2017 groups30 employees language anaveon.com

Social engagement

Social engagement: 5.3K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Forbion, Syncona.

Investor typeCountShare
Venture capital571%
Accelerator & incubator114%
Bank & private debt114%

Recent activity

2 Jul 2026
Leadership hire
Chief Scientific Officer
28 May 2026
Event
ASCO Annual Meeting 2026
19 May 2026
Leadership hire
Chief Scientific Officer
Coming soon